Authors: GEORGOULIAS V ANDROULAKIS N DIMOPOULOS AM KOUROUSIS C KAKOLYRIS S PAPADAKIS E APOSTOLOPOULOU F PAPADIMITRIOU C VOSSOS A AGELIDOU M HERAS P TZANNES S VLACHONICOLIS J MAVROMANOLAKIS E HATZIDAKI D

Citation: V. Georgoulias et al., FIRST-LINE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER WITH DOCETAXEL AND CISPLATIN - A MULTICENTER PHASE-II STUDY, Annals of oncology, 9(3), 1998, pp. 331-334

Authors: GEORGOULIAS V KOUROUSIS C ANDROULAKIS N KAKOLYRIS S PAPADAKIS E BOUROS D APOSTOLOPOULOU F GEORGOPOULOU T AGELIDOU M SOUGLAKOS J HALKIADAKIS G HATZIDAKI D

Citation: V. Georgoulias et al., DOCETAXEL (TAXOTERE) AND VINORELBINE IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 9-14

Authors: SAMANTAS E MILONAKIS M KLOUVAS G PANOUSSAKI A AGELIDOU M PALAMIDAS F BOLETI E KOSMAS E PAPADAKIS E KIAMOURIS N VARDOULAKIS T KOSMIDIS P PAVLIDIS N FOUTZILAS G SKARIOS DV

Citation: E. Samantas et al., RANDOMIZED COMPARISON OF ETOPOSIDE-CISPLATIN VS ETOPOSIDE-CARBOPLATINAND IRRADIATION IN SMALL-CELL LUNG-CANCER (SCLC) - EVALUATION OF LONG-TERM SURVIVAL, European journal of cancer, 31A, 1995, pp. 1078-1078